AVDL: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net income (loss)	4,765	4,745
Depreciation and amortization	3,008	1,893
Share-based compensation expense	14,429	9,510
Acquired in-process research & development expense	20,000	-
Other adjustments	-1,048	-786
Accounts receivable	8,347	6,534
Inventories	4,042	3,361
Prepaid expenses and other current assets	1,562	2,404
Accounts payable & other current liabilities	5,067	2,778
Accrued expenses	-1,495	2,077
Other assets and liabilities	4,105	3,453
Net cash provided by (used in) operating activities	26,670	4,465
Purchases of property and equipment	190	181
Proceeds from sales of marketable securities	57,738	45,938
Purchases of marketable securities	46,918	41,694
Upfront license payment for acquired in-process research & development	15,000	-
Net cash (used in) provided by investing activities	-4,370	4,063
Proceeds from issuance of shares off the at-the-market offering program	0	0
Proceeds from stock option exercises and employee share purchase plan	4,179	1,672
Net cash provided by financing activities	4,179	1,672
Effect of foreign currency exchange rate changes on cash and cash equivalents	1,963	1,831
Net change in cash and cash equivalents	28,442	12,031
Cash and cash equivalents at beginning of period	51,371	-
Cash and cash equivalents at end of period	79,813	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

AVDL: the cashflow